Patents by Inventor Alan Gilbert

Alan Gilbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230257319
    Abstract: Some embodiments are directed to a process for forming products from animal waste (e.g., poultry litter). The products may include a controlled release fertilizer and renewable natural gas. The process may include providing a feedstock comprising greater than about 80 percent poultry waste and a moisture content of about 25 percent. The feedstock may be diluted to form a slurry having a moisture content of about 90%. The slurry may be mechanically refined to reduce the particle size distribution and the average particle size of the slurry. The slurry may be anaerobically digested to produce biogas and a digestate. The biogas may be converted to renewable natural gas, and the digestate may be converted to a controlled release fertilizer. Additionally, some embodiments are directed to methods of reducing nitrogen emission from soil amendments. Some embodiments are directed to reducing nitrogen emissions sufficient to produce emissions offset credits.
    Type: Application
    Filed: July 16, 2021
    Publication date: August 17, 2023
    Inventors: SHAWN FREITAS, WILLIAM HOLLOMAN, BRELAND OSCAR, ALAN GILBERT, THOMAS M. SPANGLER, III, DONAL JAMES BUCKLEY, JOHN WALL, JASON LEVINE
  • Publication number: 20220048984
    Abstract: The present disclosure pertains to a mammalian cell culture genetically modified to express, and which expresses, a neublastin antibody polypeptide, or fragment thereof, in the culture, and to a neublastin antibody polypeptide, or fragment thereof, made by a mammalian cell culture genetically modified to express, and which expresses, the neublastin antibody polypeptide, or fragment thereof.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 17, 2022
    Applicant: GLORIANA THERAPEUTICS SARL
    Inventors: Alan Gilbert, Kyle Mcelearney, Terrance Michael Dobrowsky, Rashmi Riohit Kshirsagar
  • Publication number: 20210388398
    Abstract: The present invention is directed to cellulytic host cells. The host cells of the invention expressing heterologous cellulases and are able to produce ethanol from cellulose. According to the invention, host cells expressing a combination of heterologous cellulases can be used to produce ethanol from cellulose. In addition, multiple host cells expressing different heterologous cellulases can be co-cultured together and used to produce ethanol from cellulose. Furthermore, the invention demonstrates for the first time the ability of Kluyveromyces to produce ethanol from cellulose. The yeast strains and co-cultures of yeast strains of the invention can be used to produce ethanol on their own, or can also be used in combination with externally added cellulases to increase the efficiency of saccharification and fermentation processes.
    Type: Application
    Filed: December 22, 2020
    Publication date: December 16, 2021
    Inventors: John McBride, Elena Brevnova, Mark Mellon, Allan Froehlich, Kristen Deleault, Vineet Rajgarhia, Riaan Den Haan, Merja Penttila, Marja Ilmen, Matti Siika-Aho, Jaana Uusitalo, Emily A. Stonehouse, Alan Gilbert, Haowen Xu, Deidre Willies, John Bardsley, Anu Koivula, Sanni Voutilainen
  • Publication number: 20210340584
    Abstract: The present invention pertains to a cell culture medium comprising manganese as a media supplement, which was shown to control recombinant protein glycosylation and methods of using thereof. The present invention further pertains to a method of controlling or manipulating glycosylation of a recombinant protein of interest in a large scale cell culture.
    Type: Application
    Filed: November 23, 2020
    Publication date: November 4, 2021
    Applicant: Biogen MA Inc.
    Inventors: Lia Tescione, Thomas Ryll, Alan Gilbert
  • Publication number: 20200370016
    Abstract: Provided herein are methods of generating a population of enucleated erythroid cells.
    Type: Application
    Filed: May 22, 2020
    Publication date: November 26, 2020
    Applicant: Rubius Therapeutics, Inc.
    Inventors: Jonathan Lipsitz, Brian Joseph Pereira, Bryan Wang, Alan Gilbert
  • Patent number: 10844416
    Abstract: The present invention pertains to a cell culture medium comprising manganese as a media supplement, which was shown to control recombinant protein glycosylation and methods of using thereof. The present invention further pertains to a method of controlling or manipulating glycosylation of a recombinant protein of interest in a large scale cell culture.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: November 24, 2020
    Assignee: Biogen MA Inc.
    Inventors: Lia Tescione, Thomas Ryll, Alan Gilbert
  • Patent number: 10717965
    Abstract: The present disclosure pertains to a mammalian cell culture genetically modified to express, and which expresses, a neublastin antibody polypeptide, or fragment thereof, in the culture, and to a neublastin antibody polypeptide, or fragment thereof, made by a mammalian cell culture genetically modified to express, and which expresses, the neublastin antibody polypeptide, or fragment thereof.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: July 21, 2020
    Assignee: Gloriana Therapeutics, Inc.
    Inventors: Alan Gilbert, Kyle McElearney, Terrence Michael Dobrowsky, Rashmi Rohit Kshirsagar
  • Patent number: 10669523
    Abstract: The present disclosure pertains to a mammalian cell culture genetically modified to express, and which expresses, a neublastin antibody polypeptide, or fragment thereof, in the culture, and to a neublastin antibody polypeptide, or fragment thereof, made by a mammalian cell culture genetically modified to express, and which expresses, the neublastin antibody polypeptide, or fragment thereof.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: June 2, 2020
    Assignee: Gloriana Therapeutics, Inc.
    Inventors: Alan Gilbert, Kyle McElearney, Terrence Michael Dobrowsky, Rashmi Rohit Kshirsagar
  • Patent number: 10590454
    Abstract: The present invention pertains to methods of preventing and eliminating trisulfide bonds in proteins such as antibodies. In one embodiment, trisulfide bonds in proteins are converted to disulfide bonds as part of chromatographic purification procedures. In another embodiment, the formation of trisulfide bonds in proteins is inhibited by implementation of methods described herein during the cell culture production of such proteins. In another embodiment, monoclonal antibodies are produced by the methods described herein.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: March 17, 2020
    Assignee: Biogen MA Inc.
    Inventors: Rashmi Rohit Kshirsagar, Alan Gilbert
  • Patent number: 10580041
    Abstract: A playback page, which can include embedded media players and a user interface that functions as an Internet media station tuner, can be transmitted from a web server to a web browser running on a client computer. In response to receiving a message from the playback page indicating a user-selected media station, the web server transmits a message instructing the media station to transmit a tagged media stream to one media player (a Content Playback Instance), and transmits a browser file to an advertisement server. The browser file includes information used by the advertisement server to select targeted media content to be inserted into an untagged media stream delivered to another media player (an Ad Spot Playback Instance). The web server controls whether the Content Playback Instance presents a tagged media stream, or the Ad Spot Playback Instance presents targeted content, at any particular time.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: March 3, 2020
    Assignee: iHeartMedia Management Services, Inc.
    Inventors: Mark DuVall, Alan Gilbert
  • Publication number: 20190194602
    Abstract: The present disclosure pertains to a mammalian cell culture genetically modified to express, and which expresses, a neublastin antibody polypeptide, or fragment thereof, in the culture, and to a neublastin antibody polypeptide, or fragment thereof, made by a mammalian cell culture genetically modified to express, and which expresses, the neublastin antibody polypeptide, or fragment thereof.
    Type: Application
    Filed: December 21, 2018
    Publication date: June 27, 2019
    Inventors: Alan Gilbert, Kyle McElearney, Terrence Michael Dobrowsky, Rashmi Rohit Kshirsagar
  • Publication number: 20180258449
    Abstract: The present invention is directed to cellulytic host cells. The host cells of the invention expressing heterologous cellulases and are able to produce ethanol from cellulose. According to the invention, host cells expressing a combination of heterologous cellulases can be used to produce ethanol from cellulose. In addition, multiple host cells expressing different heterologous cellulases can be co-cultured together and used to produce ethanol from cellulose. Furthermore, the invention demonstrates for the first time the ability of Kluyveromyces to produce ethanol from cellulose. The yeast strains and co-cultures of yeast strains of the invention can be used to produce ethanol on their own, or can also be used in combination with externally added cellulases to increase the efficiency of saccharification and fermentation processes.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 13, 2018
    Inventors: John McBride, Elena Brevnova, Mark Mellon, Allan Froehlich, Kristen Deleault, Vineet Rajgarhia, Riaan Den Haan, Merja Penttila, Marja Ilmen, Matti Siika-Aho, Jaana Uusitalo, Emily A. Stonehouse, Alan Gilbert, Haowen Xu, Deidre Willies, John Bardsley, Anu Koivula, Sanni Voutilainen
  • Publication number: 20180251805
    Abstract: The present invention pertains to methods of preventing and eliminating trisulfide bonds in proteins such as antibodies. In one embodiment, trisulfide bonds in proteins are converted to disulfide bonds as part of chromatographic purification procedures. In another embodiment, the formation of trisulfide bonds in proteins is inhibited by implementation of methods described herein during the cell culture production of such proteins. In another embodiment, monoclonal antibodies are produced by the methods described herein.
    Type: Application
    Filed: October 16, 2017
    Publication date: September 6, 2018
    Applicant: Biogen MA Inc.
    Inventors: Rashmi Rohit Kshirsagar, Alan Gilbert
  • Publication number: 20180171362
    Abstract: Some aspects of the present disclosure provide methods, compositions and kits for identifying one or more reagents, such as a culture medium, that are effective for recombinant protein production.
    Type: Application
    Filed: June 1, 2016
    Publication date: June 21, 2018
    Applicant: Biogen MA Inc.
    Inventors: Jessica Mondia, Alan Gilbert, Maureen Lanan
  • Publication number: 20180155753
    Abstract: The present invention pertains to a cell culture medium comprising manganese as a media supplement, which was shown to control recombinant protein glycosylation and methods of using thereof. The present invention further pertains to a method of controlling or manipulating glycosylation of a recombinant protein of interest in a large scale cell culture.
    Type: Application
    Filed: June 1, 2016
    Publication date: June 7, 2018
    Applicant: Biogen MA Inc.
    Inventors: Lia Tescione, Thomas Ryll, Alan Gilbert
  • Patent number: 9988652
    Abstract: The present invention is directed to cellulytic host cells. The host cells of the invention expressing heterologous cellulases and are able to produce ethanol from cellulose. According to the invention, host cells expressing a combination of heterologous cellulases can be used to produce ethanol from cellulose. In addition, multiple host cells expressing different heterologous cellulases can be co-cultured together and used to produce ethanol from cellulose. Furthermore, the invention demonstrates for the first time the ability of Kluveryomyces to produce ethanol from cellulose. The yeast strains and co-cultures of yeast strains of the invention can be used to produce ethanol on their own, or can also be used in combination with externally added cellulases to increase the efficiency of saccharification and fermentation processes.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: June 5, 2018
    Assignees: Lallemand Hungary Liquidity Management LLC, Stellenbosch University
    Inventors: John McBride, Elena Brevnova, Mark Mellon, Allan Froehlich, Kristen Deleault, Vineet Rajgarhia, Riaan Den Haan, Merja Penttila, Marja Ilmen, Matti Siika-Aho, Jaana Uusitalo, Emily A. Stonehouse, Alan Gilbert, Haowen Xu, Deidre Willes, John Bardsley, Anu Koivula, Sanni Voutilainen
  • Publication number: 20180033046
    Abstract: A playback page, which can include embedded media players and a user interface that functions as an Internet media station tuner, can be transmitted from a web server to a web browser running on a client computer. In response to receiving a message from the playback page indicating a user-selected media station, the web server transmits a message instructing the media station to transmit a tagged media stream to one media player (a Content Playback Instance), and transmits a browser file to an advertisement server. The browser file includes information used by the advertisement server to select targeted media content to be inserted into an untagged media stream delivered to another media player (an Ad Spot Playback Instance). The web server controls whether the Content Playback Instance presents a tagged media stream, or the Ad Spot Playback Instance presents targeted content, at any particular time.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 1, 2018
    Applicant: iHeartMedia Management Services, Inc.
    Inventors: Mark DuVall, Alan Gilbert
  • Publication number: 20170327786
    Abstract: The present invention pertains to a cell culture medium comprising hypotaurine, GABA, and/or beta-alanine or the combination of choline and hypotaurine, GABA, and/or beta-alanine as media supplements which is shown to control viability, growth, and waste byproduct accumulation. The present invention further pertains to a method of producing a polypeptide of interest in a large scale cell culture containing hypotaurine, GABA, and/or beta-alanine or the combination of choline and hypotaurine, GABA, and/or beta-alanine.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 16, 2017
    Applicant: Biogen MA Inc.
    Inventors: Yao-Ming HUANG, William C. YANG, Alan GILBERT, Kyle MCELEARNEY
  • Patent number: 9805396
    Abstract: Playback of a tagged audio stream at mobile communications device, or other processing device, can be controlled transparently to a user of the device by implementing multiple instances of a media player. A Spot Caching Instance of the media player can receive and cache an untagged content stream from an advertisement server. A Content Playback Instance of the media player can be used to play back and process a tagged content stream from a radio station to identify tags. When the Content Playback Instance detects a tag, it transfers control to an Ad Spot Playback Instance of the media player, which can play back part or all of the untagged content stream from cache. When playback of the untagged content stream is completed, the Ad Spot Playback Instance transfers control back to the Content Playback Instance.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: October 31, 2017
    Assignee: iHeartMedia Management Services, Inc.
    Inventors: Mark DuVall, Alan Gilbert
  • Patent number: 9790533
    Abstract: The present invention pertains to methods of preventing and eliminating trisulfide bonds in proteins such as antibodies. In one embodiment, trisulfide bonds in proteins are converted to disulfide bonds as part of chromatographic purification procedures. In another embodiment, the formation of trisulfide bonds in proteins is inhibited by implementation of methods described herein during the cell culture production of such proteins. In another embodiment, monoclonal antibodies are produced by the methods described herein.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: October 17, 2017
    Assignee: Biogen MA Inc.
    Inventors: Rashmi Rohit Kshirsagar, Alan Gilbert